Reset Map11 Results
201 President-Kennedy, Suite 3900 Montreal, Quebec, H2X3Y7 CanadaCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
Sint-Bavostraat 78 Wilrijk Antwerpen, 2610 BelgiumCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
201 President Kennedy Ave Suite 3900 Montreal, Quebec, CN H2x 3Y7CellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
201 Avenue du Président-Kennedy, Montréal, QC H2X 3Y7, CACellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
8 Rue Adrienne Bolland, Charleroi, Wallonie 6041, BECellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
80 Empire Drive Lake Forest, California , 92630 United StatesCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
Building 1, Floor 3 Information and Industrial Park Lianhua Road No. 8 High-Tech Zone Jining, Shandong, 272000 ChinaCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
1841 centre point circle Suite 100 Naperville, IL, 60563 United StatesCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
3650 Rue St Urbain Montreal, Québec, H2X 2P2 CanadaCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
8 Rue Adrienne Bolland Charleroi, Région wallonne, 6041 BelgiumCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
101 ILSLEY AVE UNIT 5 DARTMOUTH, Nova Scotia, B3B1S8 CanadaCellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. The company partners with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Its scientific teams bring deep expertise and rigorous oversight to every program, guiding assay design, development, validation, and troubleshooting. CellCarta is adept at supporting highly customized, scientifically complex biomarker strategies as well as large-scale, standardized global studies requiring consistent execution across regions. By combining multi-modal insights, specialized scientific insight, and globally harmonized operations, CellCarta supports the full biomarker continuum — from early translational research through late-stage clinical development and companion diagnostic (CDx) advancement.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.